CNXU NASDAQ
Conexeu Sciences Inc.
1W: -20.3%
1M: -44.2%
3M: -71.3%
YTD: -76.3%
$3.10
-0.22 (-6.63%)
Weekly Expected Move ±14.6%
$2
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$83.0M
52W Range3.1-18.79
Volume114,321
Avg Volume165,440
Beta0.51
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMiles Harrison
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2026-05-21
Websiteconexeu.com
50 W Liberty St, Suite 880
Reno, NV 89501
US
Reno, NV 89501
US
604-315-4722
About Conexeu Sciences Inc.
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Latest News
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
12 Health Care Stocks Moving In Tuesday's Intraday Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Purcell Lynn Sebasti | X-InTheMoney | 217,608 | $2.30 | 2026-09-04 |
| Purcell Lynn Sebasti | X-InTheMoney | 217,608 | $2.30 | 2026-09-04 |
| Purcell Lynn Sebasti | X-InTheMoney | 217,608 | $2.30 | 2026-09-04 |
| Costa Andrew | 50,000 | $2.30 | 2026-06-15 | |
| Burke April Lynn | 50,000 | $2.30 | 2026-06-15 |